# Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease

> **NCT06897566** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 1000 (actual)

## Conditions studied

- Coronary Artery Disease
- Statin Adverse Reaction
- LDL Level

## Interventions

- **DIAGNOSTIC_TEST:** Fasting lipid profile

## Key facts

- **NCT ID:** NCT06897566
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-21
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06897566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06897566, "Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06897566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*